Gene therapy sheep study proves promising enough for human trials
A gene therapy trial originally tested in sheep, to treat a condition known as ‘day blindness’, has been approved for in-human trials.
Archives for October 23, 2018
Shire opens $1.2bn, six-years-in-the-making facility
Shire’s immune globulin infusion-producing facility will increase the company plasma manufacturing capacity by one third.
CHMP nod for Ogivri: Biocon and Mylan expect EC call by end of year
Roche remains confident new medicines will compensate for biosimilar impact, as another version of blockbuster Herceptin nears EU approval.